Elevated FGF21 concentrations are also observed in individuals with metabolic disorders, such as type 2 diabetes and obesity, who often exhibit FGF21 resistance—a reduced biological response to FGF21 despite its increased levels [12, 38]. The gene discussed is FGF21; the disease is obesity disorder.